Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript
Which Healthcare ETF Is Best for the Long Term: State Street’s XPH or Invesco’s PBE?
Septerna: The SEP-479 Readout Could Unlock Further Upside
Septerna, Inc. (SEPN) Reports Q3 Loss, Lags Revenue Estimates
Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results
Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting
Septerna to Participate in Upcoming Investor Conferences
Septerna (NASDAQ:SEPN) COO Elizabeth Bhatt Sells 4,000 Shares of Stock
CRISPR Therapeutics (NASDAQ:CRSP) & Septerna (NASDAQ:SEPN) Head-To-Head Survey
Analyzing Valneva (NASDAQ:VALN) and Septerna (NASDAQ:SEPN)
Comparing WAVE Life Sciences (NASDAQ:WVE) and Septerna (NASDAQ:SEPN)
VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 13,300 Septerna, Inc. $SEPN
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Septerna to Participate in Upcoming Investor Conferences
Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?
Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting